SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017864
Filing Date
2022-11-14
Accepted
2022-11-14 17:15:45
Documents
57
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nrbo-20220930x10q.htm   iXBRL 10-Q 1338110
2 EX-10.1 nrbo-20220930xex10d1.htm EX-10.1 48221
3 EX-31.1 nrbo-20220930xex31d1.htm EX-31.1 17137
4 EX-32.1 nrbo-20220930xex32d1.htm EX-32.1 10963
5 GRAPHIC nrbo-20220930xex10d1001.jpg GRAPHIC 3463
  Complete submission text file 0001558370-22-017864.txt   5221610

Data Files

Seq Description Document Type Size
6 EX-101.SCH nrbo-20220930.xsd EX-101.SCH 42313
7 EX-101.CAL nrbo-20220930_cal.xml EX-101.CAL 31305
8 EX-101.DEF nrbo-20220930_def.xml EX-101.DEF 171913
9 EX-101.LAB nrbo-20220930_lab.xml EX-101.LAB 378116
10 EX-101.PRE nrbo-20220930_pre.xml EX-101.PRE 270571
51 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20220930x10q_htm.xml XML 764147
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37809 | Film No.: 221387642
SIC: 2834 Pharmaceutical Preparations